Search research articles
Contact Us
Filters
Showing results (491-500 of 512) with videos related to
Page
of 52
Sort By:
European Journal of Endocrinology
|
May 5, 2021
The phenotypic spectrum associated with OTX2 mutations in humans
Louise C Gregory, Peter Gergics, Marilena Nakaguma, et al.
Human Mutation
|
September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects
Rajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Nature Communications
|
April 2, 2021
Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans
Angelica Gualtieri, Nikolina Kyprianou, Louise C Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2016
Transcription factor 7-like 1 is involved in hypothalamo-pituitary axis development in mice and humans
Carles Gaston-Massuet, Mark J McCabe, Valeria Scagliotti, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2015
Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834
Wendy B Young, James Barbosa, Peter Blomgren, et al.
Science (New York, N.Y.)
|
May 23, 2015
Ocean plankton. Patterns and ecological drivers of ocean viral communities
Jennifer R Brum, J Cesar Ignacio-Espinoza, Simon Roux, et al.
Human Mutation
|
January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension
Rajiv D Machado, Micheala A Aldred, Victoria James, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension
Ivana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
Cancer Immunology Research
|
February 7, 2025
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500
Vicky A Appleman, Atsushi Matsuda, Michelle L Ganno, et al.
Cancer Research Communications
|
November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors
Benjamin T Cooper, Wade T Iams, David B Page, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 512) with videos related to
Sort By:
Page
of 52
European Journal of Endocrinology
|
May 5, 2021
The phenotypic spectrum associated with OTX2 mutations in humans
Louise C Gregory, Peter Gergics, Marilena Nakaguma, et al.
Human Mutation
|
September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects
Rajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Nature Communications
|
April 2, 2021
Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans
Angelica Gualtieri, Nikolina Kyprianou, Louise C Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2016
Transcription factor 7-like 1 is involved in hypothalamo-pituitary axis development in mice and humans
Carles Gaston-Massuet, Mark J McCabe, Valeria Scagliotti, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2015
Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834
Wendy B Young, James Barbosa, Peter Blomgren, et al.
Science (New York, N.Y.)
|
May 23, 2015
Ocean plankton. Patterns and ecological drivers of ocean viral communities
Jennifer R Brum, J Cesar Ignacio-Espinoza, Simon Roux, et al.
Human Mutation
|
January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension
Rajiv D Machado, Micheala A Aldred, Victoria James, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension
Ivana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
Cancer Immunology Research
|
February 7, 2025
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500
Vicky A Appleman, Atsushi Matsuda, Michelle L Ganno, et al.
Cancer Research Communications
|
November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors
Benjamin T Cooper, Wade T Iams, David B Page, et al.
Page
of 52